electroCore,

electroCore, Equity

The The Equity of electroCore, (ECOR) as of Oct 18, 2026 is -1.71 M USD. In the previous year, The Equity was 7.54 M USD — a change of -122.65% (lower).

Equity

-1.71 MUSD

YoY

-122.65%

Last updated:

In 2025, electroCore,'s equity was -1.71 M USD, a -122.65% increase from the 7.54 M USD equity in the previous year.

The electroCore, Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
65.55 M USD
Jan 1, 2019
24.26 M USD
Jan 1, 2020
23.01 M USD
Jan 1, 2021
36.65 M USD
Jan 1, 2022
17.09 M USD
Jan 1, 2023
7.44 M USD
Jan 1, 2024
7.54 M USD
Jan 1, 2025
-1.71 M USD
The electroCore, Equity history
YEAREquityYoY
-1.71 MUSD-122.65%
7.54 MUSD+1.37%
7.44 MUSD-56.44%
17.09 MUSD-53.38%
36.65 MUSD+59.28%
23.01 MUSD-5.16%
24.26 MUSD-62.99%
65.55 MUSD-172.78%
-90.07 MUSD+47.53%
-61.05 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

electroCore, Stock analysis

What does electroCore, do? electroCore, Inc. is a medical device company based in Basking Ridge, New Jersey, operating in the Health Care sector. The company focuses on non-invasive vagus nerve stimulation (nVNS) therapy, offering a hand-held device called gammaCore. This device provides non-drug treatment for adults experiencing episodic cluster and migraine pain. electroCore's technology targets primary headaches, including migraine and cluster headache, as well as related chronic conditions such as gastric motility disorders, psychiatric issues, sleep disorders, and pain disorders. The company went public via an IPO on June 22, 2018, and currently employs 83 full-time staff. Its headquarters are located in Basking Ridge, and it operates within the Health Care industry. electroCore's primary product, gammaCore, is designed for non-invasive cervical vagus nerve stimulation, aiming to address neurological, psychiatric, gastroenterological, and respiratory conditions. The company's website is https://www.electrocore.com/. electroCore is listed under the ticker ECOR with ISIN US28531P2020. The firm's commercial stage operations emphasize non-invasive therapeutic solutions without pharmaceutical intervention. electroCore, is one of the most popular companies on Eulerpool.

Equity Details

Analyzing electroCore,'s Equity

electroCore,'s equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding electroCore,'s equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating electroCore,'s equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

electroCore,'s equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in electroCore,’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about electroCore, stock

The Equity of electroCore, is -1.71 M USD in 2025.

The Equity of electroCore, changed from 7.54 M USD to -1.71 M USD, representing a -122.65% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity electroCore, since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's electroCore, historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — electroCore,

All Key Metrics — electroCore,